Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Source Management Supplements Seized As Unapproved New Drugs

This article was originally published in The Tan Sheet

Executive Summary

U.S. Marshals seized several products marketed as dietary supplements from Sunrise, Fla.-based Global Source Management and Consulting's offices during a Feb. 13 raid, according to FDA

You may also be interested in...



Regulatory News In Brief

Ortho Molecular supplement claims draw warning letter; FDA flags Global Source Management violations; Zi Xiu Tang bee pollen capsules recall follows FDA buzz; Wal-Born users eligible for refunds, FTC says; GAO endorses FDA comparability approach to food import safety.

Regulatory News In Brief

Ortho Molecular supplement claims draw warning letter; FDA flags Global Source Management violations; Zi Xiu Tang bee pollen capsules recall follows FDA buzz; Wal-Born users eligible for refunds, FTC says; GAO endorses FDA comparability approach to food import safety.

Supplements For Smokers, Alcohol Users Targeted For FDA Enforcement

Dietary supplements marketed to smokers and drinkers are two of nine categories of products that "warrant close scrutiny" for enforcement, FDA says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel